Niamh Louise Pellegrini
CIK 1620611 · Chief Commercial Officer · last filed 2023-06-15
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
27
Lifetime Open-Market Net
-$1.55M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Acutus Medical, Inc. (AFIB) Delisted | Director | 20,972 | $0.09 | $1.9K | $0 | 3 | 2023-06-15 |
| NEVRO CORP (NVRO) Delisted | Chief Commercial Officer | 85,967 | $5.84 | $502.0K | -$1.55M | 21 | 2023-05-31 |
| THORATEC CORP (THOR) Delisted | President, North America | 51,928 | — | — | $0 | 3 | 2015-10-08 |
Recent Filings · Page 2 of 3
27 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-08-10 | NEVRO CORP (NVRO) Delisted | Tax (F) | −4,366 | -$522.7K | EDGAR |
| 2021-03-12 | NEVRO CORP (NVRO) Delisted | Mixed | — | -$62.3K | EDGAR |
| 2021-03-04 | NEVRO CORP (NVRO) Delisted | Mixed | +8,890 | -$118.7K | EDGAR |
| 2021-02-12 | NEVRO CORP (NVRO) Delisted | Mixed | — | -$88.2K | EDGAR |
| 2021-01-13 | NEVRO CORP (NVRO) Delisted | Mixed | — | -$78.6K | EDGAR |
| 2020-12-14 | NEVRO CORP (NVRO) Delisted | Mixed | — | -$72.2K | EDGAR |
| 2020-11-12 | NEVRO CORP (NVRO) Delisted | Mixed | — | -$79.3K | EDGAR |
| 2020-10-26 | NEVRO CORP (NVRO) Delisted | Sell (S) | −1,817 | -$299.8K | EDGAR |
| 2020-10-21 | NEVRO CORP (NVRO) Delisted | Sell (S) | −1,000 | -$155.0K | EDGAR |
| 2020-10-13 | NEVRO CORP (NVRO) Delisted | Mixed | −1,000 | -$214.9K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.